Hydrogenation of Imine Intermediates Using Platinum Catalysts

The patent applies parameter changes by carefully controlling hydrogenation conditions including temperature (0-50°C), pressure (1-10 atm), and catalyst selection (platinum on carbon or platinum dioxide) to achieve selective hydrogenation of the imine bond while preventing dehalogenation of the chlorobenzene ring. This resolves the contradiction by optimizing reaction parameters to favor the desired product.

The patent uses an imine intermediate (N-[(5-chloro-2-isopropylphenyl)methylene]cyclopropanamine) as a mediator in the synthesis pathway. By forming this intermediate first through condensation of 5-chloro-2-isopropylbenzaldehyde and cyclopropylamine, then selectively hydrogenating it, the process avoids direct reduction that would cause dehalogenation, thus improving purity while maintaining yield.

The patent converts the potential harm of dehalogenation into a benefit by using mild hydrogenation conditions that selectively reduce the imine bond while leaving the chlorobenzene ring intact. This approach prevents the formation of dehalogenation byproducts at the source, eliminating the need for complex purification processes and reducing both device complexity and operational costs.

The optimized hydrogenation process is self-service in nature, as the carefully controlled reaction conditions automatically prevent dehalogenation without requiring additional purification steps. The selectivity inherent in the reaction conditions serves the purification function, simplifying the overall process while maintaining high purity product.